TickerLeague

EBITDA for Zimmer Biomet Holdings (ZBH)

According to Zimmer Biomet Holdings's latest reported financial statements, the company's current EBITDA (TTM) is $2.22B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$2.22B

YoY change

-1.5%

5Y CAGR

+17.1%

Peak year (2024)

$2.25B

Cumulative EBITDA

$35.80B

EBITDA history chart for Zimmer Biomet Holdings (ZBH) from 1998 to 2025

EBITDA history table for Zimmer Biomet Holdings (ZBH) from 1998 to 2025

Fiscal yearPeriod endedReportedEBITDAYoY
2025$2.22B-1.5%
2024$2.25B+1.4%
2023$2.22B+48.5%
2022$1.49B-9.1%
2021$1.65B+63.6%
2020$1.01B-53.0%
2019$2.14B+102.0%
2018$1.06B-42.9%
2017$1.85B+3.3%
2016$1.79B+55.7%
2015$1.15B-16.4%
2014$1.38B-2.2%
2013$1.41B-1.1%
2012$1.43B+2.3%
2011$1.39B+10.6%
2010$1.26B-14.4%
2009$1.47B+2.7%
2008$1.43B+3.7%
2007$1.38B+1.0%
2006$1.37B+5.5%
2005$1.30B+26.5%
2004$1.03B+59.1%
2003$644.80M+51.3%
2002$426.20M+56.9%
2001$271.70M-6.7%
2000$291.10M+15.1%
1999$253.00M+6.8%
1998$237.00M

EBITDA values are taken from Zimmer Biomet Holdings's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

The 2025 reading of Zimmer Biomet Holdings (ZBH) EBITDA is $2.22B – edged down 1.5% year-over-year.

Zimmer Biomet Holdings EBITDA compound annual growth for the 2020–2025 (5 years) window is +17.1%, with the latest reading among the more recent periods of the dataset.

Zimmer Biomet Holdings EBITDA edged down from $2.25B in 2024 to $2.22B in 2025, a 1.5% drawdown.

The highest annual EBITDA of $2.25B was reported in 2024. The lowest in the available history was $237.00M in 1998.

Among 8 Healthcare peers, Zimmer Biomet Holdings (ZBH) ranks 9th; the peer median for EBITDA is $24.21B.

Zimmer Biomet Holdings EBITDA by Year

Zimmer Biomet Holdings EBITDA 2025: $2.22B

Zimmer Biomet Holdings EBITDA in 2025 was $2.22B, edged down 1.5% below 2024.

Zimmer Biomet Holdings EBITDA 2024: $2.25B

Zimmer Biomet Holdings EBITDA in 2024 was $2.25B, edged up 1.4% from 2023. This figure represents the highest annual value in the available history.

Zimmer Biomet Holdings EBITDA 2023: $2.22B

Zimmer Biomet Holdings EBITDA in 2023 was $2.22B, surged 48.5% from 2022.

Zimmer Biomet Holdings EBITDA 2022: $1.49B

Zimmer Biomet Holdings EBITDA in 2022 was $1.49B, declined 9.1% below 2021.

Zimmer Biomet Holdings EBITDA 2021: $1.65B

Zimmer Biomet Holdings EBITDA in 2021 was $1.65B.

See more financial history for Zimmer Biomet Holdings (ZBH).

Sector peers — EBITDA

Companies in the same sector as Zimmer Biomet Holdings, ranked by their latest EBITDA.

CompanyEBITDASector
Novo Nordisk A/S (NVO)$156.73BHealthcare
Johnson & Johnson (JNJ)$41.05BHealthcare
Eli Lilly and Company (LLY)$27.94BHealthcare
Merck & Co., Inc. (MRK)$25.36BHealthcare
UnitedHealth Group Incorporated (UNH)$23.06BHealthcare
AstraZeneca PLC (AZN)$19.83BHealthcare
AbbVie Inc. (ABBV)$17.63BHealthcare
Amgen Inc. (AMGN)$15.84BHealthcare

Frequently asked questions

What is Zimmer Biomet Holdings's EBITDA?

Latest reported EBITDA for Zimmer Biomet Holdings (ZBH) is $2.22B (period ending December 31, 2025).

How has Zimmer Biomet Holdings EBITDA changed year-over-year?

Zimmer Biomet Holdings (ZBH) EBITDA changed -1.5% year-over-year on the latest annual filing.

What is the long-term growth rate of Zimmer Biomet Holdings EBITDA?

Zimmer Biomet Holdings (ZBH) EBITDA compound annual growth rate is +17.1% over the most recent 5 years available.

When did Zimmer Biomet Holdings EBITDA hit its highest annual value?

Zimmer Biomet Holdings EBITDA reached its highest annual value of $2.25B in 2024.

What was Zimmer Biomet Holdings EBITDA in 2024?

Zimmer Biomet Holdings (ZBH) EBITDA in 2024 was $2.25B.

What was Zimmer Biomet Holdings EBITDA in 2025?

Zimmer Biomet Holdings (ZBH) EBITDA in 2025 was $2.22B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.